$SWK
STANLEY BLACK & DECKER, INC. Stock $swk

$swk Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000009355624000032 Filed on February 27, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$3.870B	$3.737B	$15.78B
YoY Change		-9.3%	1.05%
Cost Of Revenue	$2.761B	$2.622B	$11.68B
YoY Change		-15.45%	12.08%
Gross Profit	$1.109B	$1.114B	$4.100B
YoY Change		9.45%	-21.08%
Gross Profit Margin	28.65%	29.82%	25.98%
Selling, General & Admin	$851.8M	$810.1M	$3.390B
YoY Change		1.39%	4.75%
% of Gross Profit	76.84%	72.7%	82.7%
Research & Development			$362.0M
YoY Change			31.02%
% of Gross Profit			8.83%
Depreciation & Amortization	$140.2M	$293.1M	$625.1M
YoY Change		231.56%	91.57%
% of Gross Profit	12.65%	26.3%	15.25%
Operating Expenses	$931.8M	$903.6M	$3.685B
YoY Change		13.09%	4.9%
Operating Profit	$176.7M	$210.7M	$414.4M
YoY Change		-29.01%	-75.35%
Interest Expense	-$87.90M	-$87.60M	-$372.5M
YoY Change		-195.53%	-300.92%
% of Operating Profit	-49.75%	-41.58%	-89.89%
Other Income/Expense, Net
YoY Change
Pretax Income	$48.30M	-$78.80M	-$375.7M
YoY Change		1732.56%	1092.7%
Income Tax	$28.80M	$197.3M	-$94.00M
% Of Pretax Income	59.63%
Net Earnings	$19.50M	-$304.4M	-$310.5M
YoY Change		-136.04%	-118.38%
Net Earnings / Revenue	0.5%	-8.15%	-1.97%
Basic Earnings Per Share	$0.13		-$2.07
Diluted Earnings Per Share	$0.13	-$2.03	-$2.07
COMMON SHARES
Basic Shares Outstanding	153.8M shares	153.3M shares	149.8M shares
Diluted Shares Outstanding	150.9M shares		149.8M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$476.6M	$449.4M	$449.4M
YoY Change		9.96%	215.81%
Cash & Equivalents	$476.6M	$449.4M	$449.4M
Short-Term Investments
Other Short-Term Assets	$542.0M	$527.3M	$527.3M
YoY Change		385.1%	-61.69%
Inventory	$4.693B	$4.739B	$4.739B
Prepaid Expenses	$385.2M	$360.5M
Receivables	$1.709B	$1.302B	$1.302B
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$7.421B	$7.017B	$7.017B
YoY Change		-20.3%	-17.7%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.116B	$2.170B	$2.170B
YoY Change		-5.89%	-21.96%
Goodwill	$7.955B	$7.996B
YoY Change		-4.29%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.459B	$2.531B	$2.531B
YoY Change		63.0%	-25.33%
Total Long-Term Assets	$16.43B	$16.65B	$16.65B
YoY Change		-0.44%	-15.3%
TOTAL ASSETS
Total Short-Term Assets	$7.421B	$7.017B	$7.017B
Total Long-Term Assets	$16.43B	$16.65B	$16.65B
Total Assets	$23.85B	$23.66B	$23.66B
YoY Change		-7.29%	-16.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.338B	$2.299B	$2.299B
YoY Change		-7.78%	-33.15%
Accrued Expenses	$2.207B	$2.464B	$2.464B
YoY Change		-3.13%	7.88%
Deferred Revenue	$33.60M	$31.70M
YoY Change		3.59%
Short-Term Debt	$1.740B	$1.075B	$1.075B
YoY Change		-58.17%	-52.04%
Long-Term Debt Due	$500.0M	$1.100M	$1.100M
YoY Change		-8.33%	-15.38%
Total Short-Term Liabilities	$6.829B	$5.883B	$5.883B
YoY Change		-22.66%	-32.9%
LONG-TERM LIABILITIES
Long-Term Debt	$5.602B	$6.101B	$6.101B
YoY Change		14.03%	40.14%
Other Long-Term Liabilities	$2.253B	$2.624B	$2.624B
YoY Change		35.24%	-4.79%
Total Long-Term Liabilities	$7.855B	$8.725B	$8.725B
YoY Change		19.67%	22.72%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.829B	$5.883B	$5.883B
Total Long-Term Liabilities	$7.855B	$8.725B	$8.725B
Total Liabilities	$14.98B	$14.61B	$14.61B
YoY Change		-1.94%	-11.95%
SHAREHOLDERS EQUITY
Retained Earnings	$8.438B	$8.540B
YoY Change		-10.14%
Common Stock	$5.508B	$5.501B
YoY Change		0.65%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$8.876B	$9.056B	$9.056B
YoY Change
Total Liabilities & Shareholders Equity	$23.85B	$23.66B	$23.66B
YoY Change		-7.29%	-16.03%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$19.50M	-$304.4M	-$310.5M
YoY Change		-136.04%	-118.38%
Depreciation, Depletion And Amortization	$140.2M	$293.1M	$625.1M
YoY Change		231.56%	91.57%
Cash From Operating Activities	-$71.20M	$769.3M	$1.191B
YoY Change		-280.76%	79.66%
INVESTING ACTIVITIES
Capital Expenditures	$65.70M	$122.3M	$338.7M
YoY Change		6.91%	-34.75%
Acquisitions			$0.00
YoY Change			-100.0%
Other Investing Activities	$2.500M	$745.1M	$754.7M
YoY Change		372450.0%	18307.32%
Cash From Investing Activities	-$63.20M	$622.8M	$416.0M
YoY Change		-84.49%	-115.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$2.900M
YoY Change			-102.99%
Debt Paid & Issued, Net			$0.00
YoY Change			-100.0%
Cash From Financing Activities	548.6M	-1.320B	-1.560B
YoY Change		-61.22%	-269.77%
NET CHANGE
Cash From Operating Activities	-71.20M	769.3M	1.191B
Cash From Investing Activities	-63.20M	622.8M	416.0M
Cash From Financing Activities	548.6M	-1.320B	-1.560B
Net Change In Cash	414.2M	71.70M	47.60M
YoY Change		-32.68%	-104.31%
FREE CASH FLOW
Cash From Operating Activities	-$71.20M	$769.3M	$1.191B
Capital Expenditures	$65.70M	$122.3M	$338.7M
Free Cash Flow	-$136.9M	$647.0M	$852.6M
YoY Change		-219.81%	492.08%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	us-gaap	Impairment Of Intangible Asset Indefinite Lived Excluding Goodwill Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#AssetImpairmentCharges
CY2023	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.50
CY2022	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost Credit Excluding Service Cost Statement Of Income Or Comprehensive Income Extensible List DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList	http://fasb.org/us-gaap/2023#OtherNoninterestExpense
CY2023	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost Credit Excluding Service Cost Statement Of Income Or Comprehensive Income Extensible List DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList	http://fasb.org/us-gaap/2023#OtherNoninterestExpense
CY2022	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost Credit Excluding Service Cost Statement Of Income Or Comprehensive Income Extensible List DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList	http://fasb.org/us-gaap/2023#OtherNoninterestExpense
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2022Q4	us-gaap	Supplier Finance Program Obligation Current Statement Of Financial Position Extensible Enumeration SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#AccountsPayableCurrent
CY2023Q4	us-gaap	Supplier Finance Program Obligation Current Statement Of Financial Position Extensible Enumeration SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#AccountsPayableCurrent
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	42
CY2023	dei	Auditor Name AuditorName	Ernst & Young LLP
CY2023	dei	Auditor Location AuditorLocation	Hartford, Connecticut
CY2023	us-gaap	Revenues Revenues	15781100000	usd
CY2022	us-gaap	Revenues Revenues	16947400000	usd
CY2022	us-gaap	Revenues Revenues	15281300000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	11848500000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	12663300000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	10189100000	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3282000000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3355700000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3193100000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	8700000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	14300000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2023	us-gaap	Other Noninterest Expense OtherNoninterestExpense	320100000	usd
CY2022	us-gaap	Other Noninterest Expense OtherNoninterestExpense	274800000	usd
CY2022	us-gaap	Other Noninterest Expense OtherNoninterestExpense	189500000	usd
CY2023	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-10800000	usd
CY2022	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-8400000	usd
CY2022	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-600000	usd
CY2023	us-gaap	Restructuring Charges RestructuringCharges	39400000	usd
CY2022	us-gaap	Restructuring Charges RestructuringCharges	140800000	usd
CY2022	us-gaap	Restructuring Charges RestructuringCharges	14500000	usd
CY2023	swk	Equity Method Investment Fair Value Adjustment EquityMethodInvestmentFairValueAdjustment	0	usd
CY2022	swk	Equity Method Investment Fair Value Adjustment EquityMethodInvestmentFairValueAdjustment	0	usd
CY2022	swk	Equity Method Investment Fair Value Adjustment EquityMethodInvestmentFairValueAdjustment	68000000.0	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	274800000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	168400000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	186900000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	54700000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	9800000	usd
CY2023	us-gaap	Interest Expense InterestExpense	559400000	usd
CY2022	us-gaap	Interest Expense InterestExpense	338500000	usd
CY2022	us-gaap	Interest Expense InterestExpense	185400000	usd
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	16156800000	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	16909500000	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	13694400000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-375700000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	37900000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1586900000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-94000000.0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-132400000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	55100000	usd
CY2023	swk	Income Loss From Continuing Operations Net Of Tax Before Equity Method Investments And Noncontrolling Interest IncomeLossFromContinuingOperationsNetOfTaxBeforeEquityMethodInvestmentsAndNoncontrollingInterest	-281700000	usd
CY2022	swk	Income Loss From Continuing Operations Net Of Tax Before Equity Method Investments And Noncontrolling Interest IncomeLossFromContinuingOperationsNetOfTaxBeforeEquityMethodInvestmentsAndNoncontrollingInterest	170300000	usd
CY2022	swk	Income Loss From Continuing Operations Net Of Tax Before Equity Method Investments And Noncontrolling Interest IncomeLossFromContinuingOperationsNetOfTaxBeforeEquityMethodInvestmentsAndNoncontrollingInterest	1531800000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	19000000.0	usd
CY2023	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-281700000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	170300000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	1550800000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	0	usd
CY2022	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	200000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-1700000	usd
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-281700000	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	170100000	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	1552500000	usd
CY2023	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	usd
CY2022	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	5800000	usd
CY2022	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	14200000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-281700000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	164300000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1538300000	usd
CY2023	swk	Contract Adjustment Payments Accretion ContractAdjustmentPaymentsAccretion	0	usd
CY2022	swk	Contract Adjustment Payments Accretion ContractAdjustmentPaymentsAccretion	1200000	usd
CY2022	swk	Contract Adjustment Payments Accretion ContractAdjustmentPaymentsAccretion	1300000	usd
CY2023	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	-281700000	usd
CY2022	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	165500000	usd
CY2022	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	1539600000	usd
CY2023	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	-14300000	usd
CY2022	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	1197400000	usd
CY2023	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-14300000	usd
CY2022	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	1210900000	usd
CY2022	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	124300000	usd
CY2023	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	-14500000	usd
CY2022	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	312500000	usd
CY2023	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	14500000	usd
CY2022	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	318500000	usd
CY2022	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	-12400000	usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-28800000	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	892400000	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	136700000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-310500000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	1057900000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	1676300000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-310500000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	1062500000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	1689200000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.88
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.11
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	9.69
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.19
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	6.02
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.86
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.07
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	7.13
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	10.55
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.88
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.06
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	9.33
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.19
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	5.70
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.83
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.07
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	6.76
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	10.16
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-281700000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	164300000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1538300000	usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-28800000	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	892400000	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	136700000	usd
CY2023	swk	Net Earnings From Continuing Operations Attributable To Common Shareowners NetEarningsFromContinuingOperationsAttributableToCommonShareowners	-310500000	usd
CY2022	swk	Net Earnings From Continuing Operations Attributable To Common Shareowners NetEarningsFromContinuingOperationsAttributableToCommonShareowners	1056700000	usd
CY2022	swk	Net Earnings From Continuing Operations Attributable To Common Shareowners NetEarningsFromContinuingOperationsAttributableToCommonShareowners	1675000000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	75100000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-364400000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-307700000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	2000000.0	usd
CY2022	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	5300000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	53200000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments And Tax Parent OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTaxParent	-8900000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments And Tax Parent OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTaxParent	2000000.0	usd
CY2022	us-gaap	Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments And Tax Parent OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTaxParent	-1000000.0	usd
CY2023	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	17800000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-83200000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-123600000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	50400000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-273900000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-131900000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-260100000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	782800000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1543100000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	449400000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	395600000	usd
CY2023Q4	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	1302000000	usd
CY2022Q4	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	1231000000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	4738600000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	5861100000	usd
CY2023Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	140800000	usd
CY2022Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	360500000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	441400000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	26000000.0	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	45600000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	7017300000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	7974700000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2169900000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2353100000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	7995900000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	8502700000	usd
CY2023Q4	swk	Customer Relationship Intangible Assets Net CustomerRelationshipIntangibleAssetsNet	1445700000	usd
CY2022Q4	swk	Customer Relationship Intangible Assets Net CustomerRelationshipIntangibleAssetsNet	1821300000	usd
CY2023Q4	swk	Trade Names Net TradeNamesNet	2499300000	usd
CY2022Q4	swk	Trade Names Net TradeNamesNet	2645700000	usd
CY2023Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	4600000	usd
CY2022Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	7800000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23663800000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24963300000	usd
CY2023Q4	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	716800000	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	0	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1814300000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1658000000	usd
CY2023Q4	us-gaap	Assets Assets	23663800000	usd
CY2022Q4	us-gaap	Assets Assets	24963300000	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	1074800000	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	2102900000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1100000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1200000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2298900000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2344400000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2464300000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2120700000	usd
CY2023Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	44100000	usd
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5883200000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6569200000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	6101000000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5352900000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	333200000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	709200000	usd
CY2023Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	378400000	usd
CY2022Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	353900000	usd
CY2023Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	84800000	usd
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	0	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1827100000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2263900000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	2.50
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	2.50
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	176902738	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	176902738	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	442300000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	442300000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	8540200000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	9333300000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	5059000000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	5055600000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2069100000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2119500000	usd
CY2023Q4	swk	Stockholders Equity Subtotal StockholdersEquitySubtotal	11972400000	usd
CY2022Q4	swk	Stockholders Equity Subtotal StockholdersEquitySubtotal	12711700000	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	23282650	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	23919208	shares
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	2916300000	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	2999600000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	9056100000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	9712100000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	0	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-310500000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	1062700000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	1687500000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	432400000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	369700000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	2100000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9056100000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9714200000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	374000000.0	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	192700000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	202500000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	203100000	usd
CY2023	swk	Inventory Step Up Amortization InventoryStepUpAmortization	0	usd
CY2022	swk	Inventory Step Up Amortization InventoryStepUpAmortization	80300000	usd
CY2022	swk	Inventory Step Up Amortization InventoryStepUpAmortization	20700000	usd
CY2023	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-10800000	usd
CY2022	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-8400000	usd
CY2022	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-600000	usd
CY2023	swk	Equity Method Investment Fair Value Adjustment EquityMethodInvestmentFairValueAdjustment	0	usd
CY2022	swk	Equity Method Investment Fair Value Adjustment EquityMethodInvestmentFairValueAdjustment	0	usd
CY2022	swk	Equity Method Investment Fair Value Adjustment EquityMethodInvestmentFairValueAdjustment	68000000.0	usd
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	0	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	0	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	-101100000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	83800000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	90700000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	118300000	usd
CY2023	swk	Provision For Doubtful Accounts Including Divestiture ProvisionForDoubtfulAccountsIncludingDivestiture	8700000	usd
CY2022	swk	Provision For Doubtful Accounts Including Divestiture ProvisionForDoubtfulAccountsIncludingDivestiture	30000000.0	usd
CY2022	swk	Provision For Doubtful Accounts Including Divestiture ProvisionForDoubtfulAccountsIncludingDivestiture	18700000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	19000000.0	usd
CY2023	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-424300000	usd
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-271700000	usd
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-386900000	usd
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-154500000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-72100000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-27700000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	117000000.0	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-109000000.0	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	280600000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-906600000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	792400000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1970400000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-23000000.0	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-991400000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	758300000	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2400000	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-29900000	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1900000	usd
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-115600000	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-15600000	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	166800000	usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	175700000	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	351300000	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	438800000	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-25600000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-176300000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	444000000.0	usd
CY2023	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	-42200000	usd
CY2022	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	-31900000	usd
CY2022	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	-40000000.0	usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	113000000.0	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	173400000	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	277700000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1191300000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1459500000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	663100000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	338700000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	530400000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	519100000	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	15100000	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	41700000	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	8400000	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	71900000	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	2043800000	usd
CY2023	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	-5700000	usd
CY2022	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	4147100000	usd
CY2022	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	5300000	usd
CY2023	us-gaap	Payments For Proceeds From Hedge Investing Activities PaymentsForProceedsFromHedgeInvestingActivities	0	usd
CY2022	us-gaap	Payments For Proceeds From Hedge Investing Activities PaymentsForProceedsFromHedgeInvestingActivities	-10600000	usd
CY2022	us-gaap	Payments For Proceeds From Hedge Investing Activities PaymentsForProceedsFromHedgeInvestingActivities	55100000	usd
CY2023	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-1600000	usd
CY2022	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	24500000	usd
CY2022	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	19500000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-327700000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	3572600000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2623800000	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1500000	usd
CY2023	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	745300000	usd
CY2022	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	992600000	usd
CY2022	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	0	usd
CY2023	us-gaap	Proceeds From Repayments Of Commercial Paper ProceedsFromRepaymentsOfCommercialPaper	-1044700000	usd
CY2022	us-gaap	Proceeds From Repayments Of Commercial Paper ProceedsFromRepaymentsOfCommercialPaper	-138100000	usd
CY2022	us-gaap	Proceeds From Repayments Of Commercial Paper ProceedsFromRepaymentsOfCommercialPaper	2224600000	usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	39400000	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	39400000	usd
CY2023	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	2500000000	usd
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
CY2023	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	2500000000	usd
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	16100000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2323000000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	34300000	usd
CY2023	swk	Proceeds From Issuance Of Preferred Stock Remarketed ProceedsFromIssuanceOfPreferredStockRemarketed	0	usd
CY2022	swk	Proceeds From Issuance Of Preferred Stock Remarketed ProceedsFromIssuanceOfPreferredStockRemarketed	750000000.0	usd
CY2022	swk	Proceeds From Issuance Of Preferred Stock Remarketed ProceedsFromIssuanceOfPreferredStockRemarketed	0	usd
CY2023	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	0	usd
CY2022	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	750000000.0	usd
CY2022	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	750000000.0	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	19000000.0	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	38700000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	131400000	usd
CY2023	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	18000000.0	usd
CY2022	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	41300000	usd
CY2022	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	29300000	usd
CY2023	us-gaap	Interest Rate Cash Flow Hedge Gain Loss Reclassified To Earnings Net InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet	0	usd
CY2022	us-gaap	Interest Rate Cash Flow Hedge Gain Loss Reclassified To Earnings Net InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet	-22700000	usd
CY2022	us-gaap	Interest Rate Cash Flow Hedge Gain Loss Reclassified To Earnings Net InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet	75300000	usd
CY2023	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	482600000	usd
CY2022	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	465800000	usd
CY2022	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	474800000	usd
CY2023	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	0	usd
CY2022	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	5800000	usd
CY2022	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	18900000	usd
CY2023	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-18900000	usd
CY2022	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-11700000	usd
CY2022	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-13800000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-816000000.0	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1971100000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	918700000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2100000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-31900000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-61500000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	49700000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	110100000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1103500000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	404900000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	294800000	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1398300000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	294800000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	449400000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	395600000	usd
CY2023Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	4600000	usd
CY2022Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	9300000	usd
CY2023Q4	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	600000	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	0	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	454600000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	404900000	usd
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	11066400000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	1687500000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-131900000	usd
CY2022	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	2.98
CY2022	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	474800000	usd
CY2022	us-gaap	Preferred Stock Dividends Per Share Cash Paid PreferredStockDividendsPerShareCashPaid	50.00
CY2022	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	14200000	usd
CY2022	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	1636532	shares
CY2022	us-gaap	Stock Issued During Period Value Treasury Stock Reissued StockIssuedDuringPeriodValueTreasuryStockReissued	131400000	usd
CY2022	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	529073	shares
CY2022	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	34300000	usd
CY2022	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	1469055	shares
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	-750000000.0	usd
CY2022	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	6000000.0	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	118300000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	11592400000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	1062700000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-273900000	usd
CY2022	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	3.18
CY2022	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	465800000	usd
CY2022	us-gaap	Preferred Stock Dividends Per Share Cash Paid PreferredStockDividendsPerShareCashPaid	75.00
CY2022	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	5800000	usd
CY2022	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	988474	shares
CY2022	us-gaap	Stock Issued During Period Value Treasury Stock Reissued StockIssuedDuringPeriodValueTreasuryStockReissued	38700000	usd
CY2022	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	16057220	shares
CY2022	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	2323000000	usd
CY2022	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	4723500	shares
CY2022	swk	Remarketing And Settlement Of Purchase Contracts RemarketingAndSettlementOfPurchaseContracts	1800000	usd
CY2022	us-gaap	Preferred Stock Dividends Shares PreferredStockDividendsShares	750000	shares
CY2022	swk	Stock Issued During Period Value Remarketed Shares StockIssuedDuringPeriodValueRemarketedShares	-750000000.0	usd
CY2022	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	750000	shares
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	-750000000.0	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	90700000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9714200000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-310500000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	50400000	usd
CY2023	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	3.22
CY2023	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	482600000	usd
CY2023	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	817110	shares
CY2023	us-gaap	Stock Issued During Period Value Treasury Stock Reissued StockIssuedDuringPeriodValueTreasuryStockReissued	19000000.0	usd
CY2023	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	180552	shares
CY2023	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	16100000	usd
CY2023	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	2100000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	83800000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9056100000	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1059700000	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	66900000	usd
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1057800000	usd
CY2023	swk	Share Based Compensation Arrangements By Share Based Payment Award Number Of Years Of Service For Eligibility ShareBasedCompensationArrangementsByShareBasedPaymentAwardNumberOfYearsOfServiceForEligibility	P10Y
CY2022Q4	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	100100000	usd
CY2023Q4	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	253900000	usd
CY2022Q4	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	177800000	usd
CY2023Q4	swk	Trade Accounts And Notes Receivable Gross Current TradeAccountsAndNotesReceivableGrossCurrent	1378600000	usd
CY2022Q4	swk	Trade Accounts And Notes Receivable Gross Current TradeAccountsAndNotesReceivableGrossCurrent	1337600000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	76600000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	106600000	usd
CY2023Q4	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	1302000000	usd
CY2022Q4	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	1231000000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	106600000	usd
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	95900000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	8700000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	14300000	usd
CY2023	swk	Accounts Receivable Credit Loss Expense Reversal Charged To Other Accounts AccountsReceivableCreditLossExpenseReversalChargedToOtherAccounts	-38700000	usd
CY2022	swk	Accounts Receivable Credit Loss Expense Reversal Charged To Other Accounts AccountsReceivableCreditLossExpenseReversalChargedToOtherAccounts	-3600000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	76600000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	106600000	usd
CY2023Q4	swk	Cash Investment Purchaser Allowed To Have In Transferors Receivables CashInvestmentPurchaserAllowedToHaveInTransferorsReceivables	110000000	usd
CY2022Q4	us-gaap	Derecognized Assets Securitized Or Assetbacked Financing Arrangement Assets And Any Other Financial Assets Managed Together Principal Amount Outstanding DerecognizedAssetsSecuritizedOrAssetbackedFinancingArrangementAssetsAndAnyOtherFinancialAssetsManagedTogetherPrincipalAmountOutstanding	110000000	usd
CY2023Q4	us-gaap	Derecognized Assets Securitized Or Assetbacked Financing Arrangement Assets And Any Other Financial Assets Managed Together Principal Amount Outstanding DerecognizedAssetsSecuritizedOrAssetbackedFinancingArrangementAssetsAndAnyOtherFinancialAssetsManagedTogetherPrincipalAmountOutstanding	110000000	usd
CY2023	us-gaap	Cash Flows Between Transferee And Transferor Proceeds From New Transfers CashFlowsBetweenTransfereeAndTransferorProceedsFromNewTransfers	455700000	usd
CY2022	us-gaap	Cash Flows Between Transferee And Transferor Proceeds From New Transfers CashFlowsBetweenTransfereeAndTransferorProceedsFromNewTransfers	496400000	usd
CY2023	swk	Cash Flows Between Transferor And Transferee Payment To Purchaser CashFlowsBetweenTransferorAndTransfereePaymentToPurchaser	455700000	usd
CY2022	swk	Cash Flows Between Transferor And Transferee Payment To Purchaser CashFlowsBetweenTransferorAndTransfereePaymentToPurchaser	486400000	usd
CY2023	us-gaap	Securitization Financial Asset For Which Transfer Is Accounted As Sale Gain Loss On Sale SecuritizationFinancialAssetForWhichTransferIsAccountedAsSaleGainLossOnSale	-6300000	usd
CY2022	us-gaap	Securitization Financial Asset For Which Transfer Is Accounted As Sale Gain Loss On Sale SecuritizationFinancialAssetForWhichTransferIsAccountedAsSaleGainLossOnSale	-4100000	usd
CY2023	us-gaap	Cash Flows Between Transferee And Transferor Servicing Fees CashFlowsBetweenTransfereeAndTransferorServicingFees	900000	usd
CY2022	us-gaap	Cash Flows Between Transferee And Transferor Servicing Fees CashFlowsBetweenTransfereeAndTransferorServicingFees	900000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	116800000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	122900000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	31700000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	29600000	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	27300000	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	22900000	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	263400000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2912500000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3460800000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	338700000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1562700000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	2061600000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	4738600000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	5861100000	usd
CY2023Q4	us-gaap	Lifo Inventory Amount LIFOInventoryAmount	2800000000	usd
CY2022Q4	us-gaap	Lifo Inventory Amount LIFOInventoryAmount	3400000000	usd
CY2023Q4	us-gaap	Excess Of Replacement Or Current Costs Over Stated Lifo Value ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue	256100000	usd
CY2022Q4	us-gaap	Excess Of Replacement Or Current Costs Over Stated Lifo Value ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue	486900000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5081200000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5077900000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2911300000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2724800000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2169900000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2353100000	usd
CY2023	us-gaap	Depreciation Depreciation	383300000	usd
CY2022	us-gaap	Depreciation Depreciation	330400000	usd
CY2022	us-gaap	Depreciation Depreciation	326300000	usd
CY2023	us-gaap	Adjustment For Amortization AdjustmentForAmortization	49100000	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	39300000	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	47700000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	432400000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	369700000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	374000000.0	usd
CY2022	us-gaap	Depreciation And Amortization Discontinued Operations DepreciationAndAmortizationDiscontinuedOperations	400000	usd
CY2022	us-gaap	Depreciation And Amortization Discontinued Operations DepreciationAndAmortizationDiscontinuedOperations	23700000	usd
CY2022Q1	us-gaap	Goodwill Goodwill	8590700000	usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	90500000	usd
CY2022	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-178500000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	8502700000	usd
CY2023	us-gaap	Goodwill Transfers GoodwillTransfers	540500000	usd
CY2023	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	33700000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	7995900000	usd
CY2023Q3	us-gaap	Number Of Reporting Units NumberOfReportingUnits	3	reportingunit
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2958400000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1405200000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3284300000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1325500000	usd
CY2023Q4	us-gaap	Indefinite Lived Trade Names IndefiniteLivedTradeNames	2396000000	usd
CY2022Q4	us-gaap	Indefinite Lived Trade Names IndefiniteLivedTradeNames	2516000000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	192700000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	202500000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	203100000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	163700000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	150200000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	142300000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	135100000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	131300000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	830600000	usd
CY2023Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	318300000	usd
CY2022Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	192000000.0	usd
CY2023Q4	swk	Accrued Income Taxes And Other Current AccruedIncomeTaxesAndOtherCurrent	288500000	usd
CY2022Q4	swk	Accrued Income Taxes And Other Current AccruedIncomeTaxesAndOtherCurrent	260700000	usd
CY2023Q4	swk	Accrued Rebates And Returns AccruedRebatesAndReturns	411200000	usd
CY2022Q4	swk	Accrued Rebates And Returns AccruedRebatesAndReturns	376600000	usd
CY2023Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	71800000	usd
CY2022Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	95300000	usd
CY2023Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	28900000	usd
CY2022Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	62300000	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	17900000	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	16100000	usd
CY2023Q4	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	109500000	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	99800000	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	31700000	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	29600000	usd
CY2023Q4	swk	Accrued Freight Costs AccruedFreightCosts	107100000	usd
CY2022Q4	swk	Accrued Freight Costs AccruedFreightCosts	220300000	usd
CY2023Q4	us-gaap	Accrued Environmental Loss Contingencies Current AccruedEnvironmentalLossContingenciesCurrent	46000000.0	usd
CY2022Q4	us-gaap	Accrued Environmental Loss Contingencies Current AccruedEnvironmentalLossContingenciesCurrent	39400000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	127700000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	114100000	usd
CY2023Q4	swk	Forward Stock Purchase Contract ForwardStockPurchaseContract	337400000	usd
CY2022Q4	swk	Forward Stock Purchase Contract ForwardStockPurchaseContract	0	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	64000000.0	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	49000000.0	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	504300000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	565500000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2464300000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2120700000	usd
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	6154400000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	5900000	usd
CY2023Q4	us-gaap	Deferred Gain Loss On Discontinuation Of Fair Value Hedge DeferredGainLossOnDiscontinuationOfFairValueHedge	-19700000	usd
CY2023	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	10100000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	36800000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	6102100000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	5354100000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1100000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1200000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	6101000000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5352900000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1100000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	500500000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	902800000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	1100000000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	3650000000	usd
CY2023Q4	swk	Fair Value Adjustment Of Interest Rate Swap FairValueAdjustmentOfInterestRateSwap	-25600000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	36800000	usd
CY2023	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	745300000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	4700000	usd
CY2022Q1	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	992600000	usd
CY2022Q1	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	7400000	usd
CY2023Q4	swk	Commercial Paper Amount Outstanding CommercialPaperAmountOutstanding	1100000000	usd
CY2022Q4	swk	Commercial Paper Amount Outstanding CommercialPaperAmountOutstanding	2100000000	usd
CY2023Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	4300000000	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	1100000000	usd
CY2023	us-gaap	Interest Paid InterestPaid	531500000	usd
CY2022	us-gaap	Interest Paid InterestPaid	320800000	usd
CY2022	us-gaap	Interest Paid InterestPaid	177100000	usd
CY2023Q1	swk	Debt Instrument Adjustment Addback Amount DebtInstrumentAdjustmentAddbackAmount	500000000	usd
CY2023Q1	swk	Debt Instrument Lower Minimum Interest Coverage Ratio DebtInstrumentLowerMinimumInterestCoverageRatio	3.5
CY2023Q1	swk	Debt Instrument Lower Minimum Interest Coverage Ratio DebtInstrumentLowerMinimumInterestCoverageRatio	1.5
CY2023Q1	swk	Debt Instrument Minimum Interest Coverage Ratio DebtInstrumentMinimumInterestCoverageRatio	3.5
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	8500000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	12200000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	417600000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	16100000	usd
CY2023	swk	Payments For Proceeds From Derivative Instruments PaymentsForProceedsFromDerivativeInstruments	30100000	usd
CY2022	swk	Payments For Proceeds From Derivative Instruments PaymentsForProceedsFromDerivativeInstruments	-86200000	usd
CY2022	swk	Payments For Proceeds From Derivative Instruments PaymentsForProceedsFromDerivativeInstruments	166800000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	11848500000	usd
CY2023	us-gaap	Interest Expense InterestExpense	559400000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	12663300000	usd
CY2022	us-gaap	Interest Expense InterestExpense	338500000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	10189100000	usd
CY2022	us-gaap	Interest Expense InterestExpense	185400000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	-3600000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	26400000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	-17000000	usd
CY2023	us-gaap	Interest Expense InterestExpense	559400000	usd
CY2022	us-gaap	Interest Expense InterestExpense	338500000	usd
CY2022	us-gaap	Interest Expense InterestExpense	185400000	usd
CY2023Q4	us-gaap	Hedging Liabilities Current HedgingLiabilitiesCurrent	1100000	usd
CY2023Q4	us-gaap	Hedging Liabilities Noncurrent HedgingLiabilitiesNoncurrent	532600000	usd
CY2022Q4	us-gaap	Hedging Liabilities Current HedgingLiabilitiesCurrent	1200000	usd
CY2022Q4	us-gaap	Hedging Liabilities Noncurrent HedgingLiabilitiesNoncurrent	533100000	usd
CY2023	swk	Non Derivative Instrument Gain Loss Recognizedin Other Comprehensive Income Loss Effective Portion Net NonDerivativeInstrumentGainLossRecognizedinOtherComprehensiveIncomeLossEffectivePortionNet	-12000000.0	usd
CY2023	swk	Non Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net NonDerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet	0	usd
CY2023	swk	Non Derivative Instruments Gain Loss Amortized From Accumulated Other Comprehensive Income Into Income Net NonDerivativeInstrumentsGainLossAmortizedFromAccumulatedOtherComprehensiveIncomeIntoIncomeNet	0	usd
CY2022	swk	Non Derivative Instrument Gain Loss Recognizedin Other Comprehensive Income Loss Effective Portion Net NonDerivativeInstrumentGainLossRecognizedinOtherComprehensiveIncomeLossEffectivePortionNet	-100000	usd
CY2022	swk	Non Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net NonDerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet	0	usd
CY2022	swk	Non Derivative Instruments Gain Loss Amortized From Accumulated Other Comprehensive Income Into Income Net NonDerivativeInstrumentsGainLossAmortizedFromAccumulatedOtherComprehensiveIncomeIntoIncomeNet	0	usd
CY2022	swk	Non Derivative Instrument Gain Loss Recognizedin Other Comprehensive Income Loss Effective Portion Net NonDerivativeInstrumentGainLossRecognizedinOtherComprehensiveIncomeLossEffectivePortionNet	-6700000	usd
CY2022	swk	Non Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net NonDerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet	0	usd
CY2022	swk	Non Derivative Instruments Gain Loss Amortized From Accumulated Other Comprehensive Income Into Income Net NonDerivativeInstrumentsGainLossAmortizedFromAccumulatedOtherComprehensiveIncomeIntoIncomeNet	0	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-281700000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	164300000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1538300000	usd
CY2023	swk	Contract Adjustment Payments Accretion ContractAdjustmentPaymentsAccretion	0	usd
CY2022	swk	Contract Adjustment Payments Accretion ContractAdjustmentPaymentsAccretion	1200000	usd
CY2022	swk	Contract Adjustment Payments Accretion ContractAdjustmentPaymentsAccretion	1300000	usd
CY2023	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	-281700000	usd
CY2022	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	165500000	usd
CY2022	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	1539600000	usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-28800000	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	892400000	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	136700000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-310500000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	1057900000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	1676300000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	149751000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	148170000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	158760000	shares
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	8383000	shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	6264000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	149751000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	156553000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	165024000	shares
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.88
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.11
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	9.69
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.19
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	6.02
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.86
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.07
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	7.13
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	10.55
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.88
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.06
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	9.33
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.19
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	5.70
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.83
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.07
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	6.76
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	10.16
CY2019Q4	swk	Common Stock Forward Purchase Contract Term CommonStockForwardPurchaseContractTerm	P3Y
CY2022	swk	Increase In Weighted Average Number Of Shares Outstanding IncreaseInWeightedAverageNumberOfSharesOutstanding	3600000	shares
CY2017Q2	swk	Common Stock Forward Purchase Contract Term CommonStockForwardPurchaseContractTerm	P3Y
CY2020Q2	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	1000
CY2021Q2	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	1469055	shares
CY2021Q2	swk	Preferred Stock Redemption Price Per Share Before Redemption Date PreferredStockRedemptionPricePerShareBeforeRedemptionDate	148.04
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5281713	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	140.22
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	848394	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	89.87
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	85925	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	82.93
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	553334	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	141.37
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5490848	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	133.22
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	152983530	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	163328776	shares
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	160752262	shares
CY2023	us-gaap	Stock Issued During Period Shares Treasury Stock Reissued StockIssuedDuringPeriodSharesTreasuryStockReissued	817110	shares
CY2022	us-gaap	Stock Issued During Period Shares Treasury Stock Reissued StockIssuedDuringPeriodSharesTreasuryStockReissued	5711974	shares
CY2022	us-gaap	Stock Issued During Period Shares Treasury Stock Reissued StockIssuedDuringPeriodSharesTreasuryStockReissued	3105587	shares
CY2023	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	180552	shares
CY2022	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	16057220	shares
CY2022	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	529073	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	153620088	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	152983530	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	163328776	shares
CY2023Q4	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	3645510	shares
CY2022Q4	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	3645510	shares
CY2022Q1	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	3645510	shares
CY2023Q4	swk	Common Stock Shares Outstanding Excluding Shares Subject To Forward Purchase Contract CommonStockSharesOutstandingExcludingSharesSubjectToForwardPurchaseContract	149974578	shares
CY2022Q4	swk	Common Stock Shares Outstanding Excluding Shares Subject To Forward Purchase Contract CommonStockSharesOutstandingExcludingSharesSubjectToForwardPurchaseContract	149338020	shares
CY2022Q1	swk	Common Stock Shares Outstanding Excluding Shares Subject To Forward Purchase Contract CommonStockSharesOutstandingExcludingSharesSubjectToForwardPurchaseContract	159683266	shares
CY2022Q4	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	4723500	shares
CY2015Q1	us-gaap	Forward Contract Indexed To Issuers Equity Shares ForwardContractIndexedToIssuersEquityShares	3645510	shares
CY2015Q1	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	350000000	usd
CY2023Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	7231476	shares
CY2022Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	9655464	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3877759	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	144.12
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	7100000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	200000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1000000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	4600000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	85300000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5490848	shares
CY2023	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P6Y2M19D
CY2023Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	133.22
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3877759	shares
CY2023	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P5Y1M28D
CY2023Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	144.12
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	21900000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	5600000	usd
CY2023	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	1500000	usd
CY2022	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	9800000	usd
CY2022	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	1100000	usd
CY2023Q4	swk	Share Based Compensation Arrangement By Share Based Payment Award Number Of Annual Performance Goals ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAnnualPerformanceGoals	2	goal
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1	P3Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1	P3Y
CY2023	swk	Return On Capital Employed As Percentage Of Share Based Payment ReturnOnCapitalEmployedAsPercentageOfShareBasedPayment	0.75
CY2022	swk	Return On Capital Employed As Percentage Of Share Based Payment ReturnOnCapitalEmployedAsPercentageOfShareBasedPayment	0.75
CY2022	swk	Return On Capital Employed As Percentage Of Share Based Payment ReturnOnCapitalEmployedAsPercentageOfShareBasedPayment	0.75
CY2023	swk	Return On Capital Employed As Percentage Of Share Based Payment ReturnOnCapitalEmployedAsPercentageOfShareBasedPayment	0.75
CY2022	swk	Return On Capital Employed As Percentage Of Share Based Payment ReturnOnCapitalEmployedAsPercentageOfShareBasedPayment	0.75
CY2022	swk	Return On Capital Employed As Percentage Of Share Based Payment ReturnOnCapitalEmployedAsPercentageOfShareBasedPayment	0.75
CY2023	swk	Market Based Elements As Percentage Of Share Based Payment MarketBasedElementsAsPercentageOfShareBasedPayment	0.25
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1	P3Y
CY2022	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-219500000	usd
CY2022	swk	Other Comprehensive Income Loss Adjustments For Disposition Of Business OtherComprehensiveIncomeLossAdjustmentsForDispositionOfBusiness	-36100000	usd
CY2022	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	18300000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-273900000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	37700000	usd
CY2023	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-12700000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	50400000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	38800000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	28900000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	31100000	usd
CY2023	us-gaap	Employee Stock Ownership Plan Esop Gain Loss On Transactions In Deferred Shares EmployeeStockOwnershipPlanESOPGainLossOnTransactionsInDeferredShares	-71600000	usd
CY2022	us-gaap	Employee Stock Ownership Plan Esop Gain Loss On Transactions In Deferred Shares EmployeeStockOwnershipPlanESOPGainLossOnTransactionsInDeferredShares	-61100000	usd
CY2022	us-gaap	Employee Stock Ownership Plan Esop Gain Loss On Transactions In Deferred Shares EmployeeStockOwnershipPlanESOPGainLossOnTransactionsInDeferredShares	-59100000	usd
CY2023Q4	swk	Defined Contribution Plan Liability DefinedContributionPlanLiability	104700000	usd
CY2022Q4	swk	Defined Contribution Plan Liability DefinedContributionPlanLiability	95600000	usd
CY2023	us-gaap	Multiemployer Plan Employer Contribution Cost MultiemployerPlanEmployerContributionCost	3500000	usd
CY2022	us-gaap	Multiemployer Plan Employer Contribution Cost MultiemployerPlanEmployerContributionCost	6000000.0	usd
CY2022	us-gaap	Multiemployer Plan Employer Contribution Cost MultiemployerPlanEmployerContributionCost	7100000	usd
CY2023	us-gaap	Defined Benefit Plan Other Costs DefinedBenefitPlanOtherCosts	43300000	usd
CY2022	us-gaap	Defined Benefit Plan Other Costs DefinedBenefitPlanOtherCosts	-2400000	usd
CY2022	us-gaap	Defined Benefit Plan Other Costs DefinedBenefitPlanOtherCosts	28600000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Net Unamortized Gain Loss Arising During Period Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax	28800000	usd
CY2023	swk	Defined Benefit Plan Other Comprehensive Income Amortization Of Actuarial Gain Loss During Period Before Tax DefinedBenefitPlanOtherComprehensiveIncomeAmortizationOfActuarialGainLossDuringPeriodBeforeTax	-11100000	usd
CY2023	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Cost Credit Arising During Period Before Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax	0	usd
CY2023	us-gaap	Defined Benefit Plan Recognized Net Gain Loss Due To Settlements And Curtailments1 DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1	-1000000.0	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	8000000.0	usd
CY2023	us-gaap	Defined Benefit Plan Amounts Recognized In Other Comprehensive Income Loss Net Gain Loss Before Tax DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax	24700000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Accumulated Benefit Obligation DefinedBenefitPlanAccumulatedBenefitObligation	2084000000.000	usd
CY2022Q4	us-gaap	Defined Benefit Plan Accumulated Benefit Obligation DefinedBenefitPlanAccumulatedBenefitObligation	2023000000.000	usd
CY2023	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets	0.0599
CY2023	swk	Defined Benefit Plan Percentage Of Pension Liability Invested In Fixed Income Securities DefinedBenefitPlanPercentageOfPensionLiabilityInvestedInFixedIncomeSecurities	0.50
CY2023	swk	Defined Benefit Plan Target Allocation Percentage Of Assetsequity Securities Range Minimum DefinedBenefitPlanTargetAllocationPercentageOfAssetsequitySecuritiesRangeMinimum	0.10
CY2023	swk	Defined Benefit Plan Target Allocation Percentage Of Assets Equity Securities Range Maximum DefinedBenefitPlanTargetAllocationPercentageOfAssetsEquitySecuritiesRangeMaximum	0.30
CY2023	swk	Defined Benefit Plan Target Allocation Percentage Of Assets Fixed Income Securities Range Minimum DefinedBenefitPlanTargetAllocationPercentageOfAssetsFixedIncomeSecuritiesRangeMinimum	0.60
CY2023	swk	Defined Benefit Plan Target Allocation Percentage Of Assets Fixed Income Securities Range Maximum DefinedBenefitPlanTargetAllocationPercentageOfAssetsFixedIncomeSecuritiesRangeMaximum	0.80
CY2023	swk	Defined Benefit Plan Target Allocation Percentage Of Assets Alternative Investments Range Maximum DefinedBenefitPlanTargetAllocationPercentageOfAssetsAlternativeInvestmentsRangeMaximum	0.10
CY2022Q1	us-gaap	Defined Benefit Plan Funded Percentage DefinedBenefitPlanFundedPercentage	0.87
CY2023Q4	us-gaap	Defined Benefit Plan Funded Percentage DefinedBenefitPlanFundedPercentage	0.87
CY2022Q4	us-gaap	Defined Benefit Plan Funded Percentage DefinedBenefitPlanFundedPercentage	0.87
CY2023Q4	us-gaap	Defined Benefit Plan Expected Future Employer Contributions Next Fiscal Year DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear	35000000	usd
CY2023Q4	swk	Defined Benefit Plan Expected Future Benefit Payments DefinedBenefitPlanExpectedFutureBenefitPayments	1489800000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Next Twelve Months DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths	160100000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Two DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo	149800000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Three DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree	149500000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Four DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour	148600000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Five DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive	148400000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Five Fiscal Years Thereafter DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter	733400000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Health Care Cost Trend Rate Assumed Next Fiscal Year DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear	0.066
CY2023Q4	us-gaap	Defined Benefit Plan Ultimate Health Care Cost Trend Rate1 DefinedBenefitPlanUltimateHealthCareCostTrendRate1	0.049
CY2023	us-gaap	Other Noninterest Expense OtherNoninterestExpense	320100000	usd
CY2022	us-gaap	Other Noninterest Expense OtherNoninterestExpense	274800000	usd
CY2022	us-gaap	Other Noninterest Expense OtherNoninterestExpense	189500000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	362000000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	357400000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	276300000	usd
CY2022Q4	us-gaap	Restructuring Reserve RestructuringReserve	62300000	usd
CY2023	us-gaap	Restructuring Charges RestructuringCharges	39400000	usd
CY2023	us-gaap	Payments For Restructuring PaymentsForRestructuring	72400000	usd
CY2023	us-gaap	Restructuring Reserve Translation Adjustment RestructuringReserveTranslationAdjustment	-400000	usd
CY2023Q4	us-gaap	Restructuring Reserve RestructuringReserve	28900000	usd
CY2023Q4	us-gaap	Restructuring Reserve RestructuringReserve	28900000	usd
CY2023	us-gaap	Restructuring Charges RestructuringCharges	39400000	usd
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2023	us-gaap	Revenues Revenues	15781100000	usd
CY2022	us-gaap	Revenues Revenues	16947400000	usd
CY2022	us-gaap	Revenues Revenues	15281300000	usd
CY2023	swk	Corporate Overhead Expense CorporateOverheadExpense	312200000	usd
CY2022	swk	Corporate Overhead Expense CorporateOverheadExpense	294000000.0	usd
CY2022	swk	Corporate Overhead Expense CorporateOverheadExpense	342900000	usd
CY2023	us-gaap	Other Noninterest Expense OtherNoninterestExpense	320100000	usd
CY2022	us-gaap	Other Noninterest Expense OtherNoninterestExpense	274800000	usd
CY2022	us-gaap	Other Noninterest Expense OtherNoninterestExpense	189500000	usd
CY2023	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-10800000	usd
CY2022	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-8400000	usd
CY2022	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-600000	usd
CY2023	us-gaap	Restructuring Charges RestructuringCharges	39400000	usd
CY2022	us-gaap	Restructuring Charges RestructuringCharges	140800000	usd
CY2022	us-gaap	Restructuring Charges RestructuringCharges	14500000	usd
CY2023	swk	Equity Method Investment Fair Value Adjustment EquityMethodInvestmentFairValueAdjustment	0	usd
CY2022	swk	Equity Method Investment Fair Value Adjustment EquityMethodInvestmentFairValueAdjustment	0	usd
CY2022	swk	Equity Method Investment Fair Value Adjustment EquityMethodInvestmentFairValueAdjustment	68000000.0	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	274800000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	168400000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	186900000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	54700000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	9800000	usd
CY2023	us-gaap	Interest Expense InterestExpense	559400000	usd
CY2022	us-gaap	Interest Expense InterestExpense	338500000	usd
CY2022	us-gaap	Interest Expense InterestExpense	185400000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-375700000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	37900000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1586900000	usd
CY2023	swk	Disposal Group Including Discontinued Operations Payments To Acquire Productive Assets DisposalGroupIncludingDiscontinuedOperationsPaymentsToAcquireProductiveAssets	0	usd
CY2022	swk	Disposal Group Including Discontinued Operations Payments To Acquire Productive Assets DisposalGroupIncludingDiscontinuedOperationsPaymentsToAcquireProductiveAssets	6300000	usd
CY2022	swk	Disposal Group Including Discontinued Operations Payments To Acquire Productive Assets DisposalGroupIncludingDiscontinuedOperationsPaymentsToAcquireProductiveAssets	20000000.0	usd
CY2023	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	338700000	usd
CY2022	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	530400000	usd
CY2022	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	519100000	usd
CY2023	us-gaap	Disposal Group Including Discontinued Operation Depreciation And Amortization DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization	0	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation Depreciation And Amortization DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization	400000	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation Depreciation And Amortization DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization	62800000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	625100000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	572200000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	577100000	usd
CY2023Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	857600000	usd
CY2022Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	0	usd
CY2023Q4	us-gaap	Assets Assets	23663800000	usd
CY2022Q4	us-gaap	Assets Assets	24963300000	usd
CY2023	us-gaap	Revenues Revenues	15781100000	usd
CY2022	us-gaap	Revenues Revenues	16947400000	usd
CY2022	us-gaap	Revenues Revenues	15281300000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2169900000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2353100000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	114600000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	160100000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	817700000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	907500000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	14800000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	45400000	usd
CY2023Q4	swk	Deferred Tax Liability Lease Right Of Use Asset DeferredTaxLiabilityLeaseRightOfUseAsset	126500000	usd
CY2022Q4	swk	Deferred Tax Liability Lease Right Of Use Asset DeferredTaxLiabilityLeaseRightOfUseAsset	108200000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts	32600000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts	59400000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	44200000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	46700000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1150400000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1327300000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	154800000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	130900000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	100800000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	104000000.0	usd
CY2023Q4	swk	Deferred Tax Assets Operating Loss And Capital Loss Carryforwards DeferredTaxAssetsOperatingLossAndCapitalLossCarryforwards	826500000	usd
CY2022Q4	swk	Deferred Tax Assets Operating Loss And Capital Loss Carryforwards DeferredTaxAssetsOperatingLossAndCapitalLossCarryforwards	817400000	usd
CY2023Q4	swk	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	129100000	usd
CY2022Q4	swk	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	110400000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	681300000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	556800000	usd
CY2023Q4	swk	Deferred Tax Asset Basis Difference In Debt Obligation DeferredTaxAssetBasisDifferenceInDebtObligation	249100000	usd
CY2022Q4	swk	Deferred Tax Asset Basis Difference In Debt Obligation DeferredTaxAssetBasisDifferenceInDebtObligation	268000000.0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	194600000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	134700000	usd
CY2023Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	152700000	usd
CY2022Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	27700000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	159100000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	176600000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2648000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2326500000	usd
CY2023Q4	swk	Deferred Tax Assets Liabilities Gross DeferredTaxAssetsLiabilitiesGross	1497600000	usd
CY2022Q4	swk	Deferred Tax Assets Liabilities Gross DeferredTaxAssetsLiabilitiesGross	999200000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1046900000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1032500000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	450700000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	33300000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1046900000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1032500000	usd
CY2023	us-gaap	Undistributed Earnings UndistributedEarnings	4600000000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	14800000	usd
CY2023Q4	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	1000000000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-1385000000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-1233800000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-77700000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	1009300000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	1271700000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	1664600000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-375700000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	37900000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1586900000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	5800000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-79000000.0	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	300000	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	307400000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	248600000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	388000000.0	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	17100000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-16700000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	31800000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	330300000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	152900000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	420100000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-158200000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-61200000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-124700000	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-218300000	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-222500000	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-210100000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-47800000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1600000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-30200000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-424300000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-285300000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-365000000.0	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-94000000.0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-132400000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	55100000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	415200000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	482600000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	441800000	usd
CY2023	swk	Income Tax Refund IncomeTaxRefund	25300000	usd
CY2022	swk	Income Tax Refund IncomeTaxRefund	41800000	usd
CY2022	swk	Income Tax Refund IncomeTaxRefund	50100000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-78900000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	8000000.0	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	333200000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-23600000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-19300000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1400000	usd
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-48000000.0	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-28800000	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-63500000	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	30500000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	26300000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	49600000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	33500000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-25100000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-11900000	usd
CY2023	swk	Income Tax Reconciliation Change In Undistributed Earnings IncomeTaxReconciliationChangeInUndistributedEarnings	0	usd
CY2022	swk	Income Tax Reconciliation Change In Undistributed Earnings IncomeTaxReconciliationChangeInUndistributedEarnings	-12800000	usd
CY2022	swk	Income Tax Reconciliation Change In Undistributed Earnings IncomeTaxReconciliationChangeInUndistributedEarnings	-23100000	usd
CY2023	swk	Effective Income Tax Rate Reconciliation Stock Based Compensation EffectiveIncomeTaxRateReconciliationStockBasedCompensation	8200000	usd
CY2022	swk	Effective Income Tax Rate Reconciliation Stock Based Compensation EffectiveIncomeTaxRateReconciliationStockBasedCompensation	7300000	usd
CY2022	swk	Effective Income Tax Rate Reconciliation Stock Based Compensation EffectiveIncomeTaxRateReconciliationStockBasedCompensation	-6300000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	200000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-5500000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-31100000	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	13800000	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	8800000	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	6700000	usd
CY2023	swk	Effective Income Tax Rate Reconciliation Tax Expense Benefit On Foreign Earnings EffectiveIncomeTaxRateReconciliationTaxExpenseBenefitOnForeignEarnings	61100000	usd
CY2022	swk	Effective Income Tax Rate Reconciliation Tax Expense Benefit On Foreign Earnings EffectiveIncomeTaxRateReconciliationTaxExpenseBenefitOnForeignEarnings	55700000	usd
CY2022	swk	Effective Income Tax Rate Reconciliation Tax Expense Benefit On Foreign Earnings EffectiveIncomeTaxRateReconciliationTaxExpenseBenefitOnForeignEarnings	-118100000	usd
CY2023	swk	Effective Income Tax Rate Reconciliation Intra Entity Transfer Of Intellectual Property EffectiveIncomeTaxRateReconciliationIntraEntityTransferOfIntellectualProperty	-131300000	usd
CY2022	swk	Effective Income Tax Rate Reconciliation Intra Entity Transfer Of Intellectual Property EffectiveIncomeTaxRateReconciliationIntraEntityTransferOfIntellectualProperty	-153300000	usd
CY2022	swk	Effective Income Tax Rate Reconciliation Intra Entity Transfer Of Intellectual Property EffectiveIncomeTaxRateReconciliationIntraEntityTransferOfIntellectualProperty	-114200000	usd
CY2023	swk	Effective Income Tax Rate Reconciliation Withholding Taxes EffectiveIncomeTaxRateReconciliationWithholdingTaxes	38900000	usd
CY2022	swk	Effective Income Tax Rate Reconciliation Withholding Taxes EffectiveIncomeTaxRateReconciliationWithholdingTaxes	5400000	usd
CY2022	swk	Effective Income Tax Rate Reconciliation Withholding Taxes EffectiveIncomeTaxRateReconciliationWithholdingTaxes	12000000.0	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	30400000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	0	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	0	usd
CY2023	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-1200000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-7100000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-12400000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-94000000.0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-132400000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	55100000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	502700000	usd
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	487700000	usd
CY2021Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	428300000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	20900000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	27200000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	33600000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	20400000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	41100000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	53500000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	8200000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	37800000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	17200000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	16200000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	7000000.0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	1300000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	16800000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	8500000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	9200000	usd
CY2023	swk	Unrecognized Tax Benefits Reclassification To Long Term Liabilities Held For Sale UnrecognizedTaxBenefitsReclassificationToLongTermLiabilitiesHeldForSale	21500000	usd
CY2022	swk	Unrecognized Tax Benefits Reclassification To Long Term Liabilities Held For Sale UnrecognizedTaxBenefitsReclassificationToLongTermLiabilitiesHeldForSale	0	usd
CY2022	swk	Unrecognized Tax Benefits Reclassification To Long Term Liabilities Held For Sale UnrecognizedTaxBenefitsReclassificationToLongTermLiabilitiesHeldForSale	0	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	481300000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	502700000	usd
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	487700000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	475700000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	496000000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	15500000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	-11200000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	9600000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	64300000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	48800000	usd
CY2022Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	60000000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	502900000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	431500000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	506600000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	440500000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.046
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.036
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y
CY2023	swk	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Operating Lease Right Of Use Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets	206100000	usd
CY2022	swk	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Operating Lease Right Of Use Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets	115800000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	144000000.0	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	147100000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	126300000	usd
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	31200000	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	27600000	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	25500000	usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	11200000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	5900000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	5900000	usd
CY2023	us-gaap	Sublease Income SubleaseIncome	3200000	usd
CY2022	us-gaap	Sublease Income SubleaseIncome	2500000	usd
CY2022	us-gaap	Sublease Income SubleaseIncome	1300000	usd
CY2023	us-gaap	Lease Cost LeaseCost	183200000	usd
CY2022	us-gaap	Lease Cost LeaseCost	178100000	usd
CY2022	us-gaap	Lease Cost LeaseCost	156400000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	128300000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	124100000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	110800000	usd
CY2023Q4	swk	Lessee Operating Lease Liability To Be Paid Including Discontinued Operations LesseeOperatingLeaseLiabilityToBePaidIncludingDiscontinuedOperations	613000000.0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	135400000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	105700000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	90500000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	69500000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	56300000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	155600000	usd
CY2023Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance Sheet Amount UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount	199100000	usd
CY2023Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On First Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary	87800000	usd
CY2023Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On Second Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary	44000000.0	usd
CY2023Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On Third Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary	37900000	usd
CY2023Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On Fourth Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary	22100000	usd
CY2023Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On Fifth Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnFifthAnniversary	7300000	usd
CY2023Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Due After Five Years UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears	0	usd
CY2023Q4	us-gaap	Supplier Finance Program Obligation Current SupplierFinanceProgramObligationCurrent	528100000	usd
CY2022Q4	us-gaap	Supplier Finance Program Obligation Current SupplierFinanceProgramObligationCurrent	607500000	usd
CY2023Q4	us-gaap	Guarantee Obligations Maximum Exposure GuaranteeObligationsMaximumExposure	436000000.0	usd
CY2023Q4	us-gaap	Guarantee Obligations Current Carrying Value GuaranteeObligationsCurrentCarryingValue	15500000	usd
CY2023	swk	Product Warranties Term ProductWarrantiesTerm	P1Y
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	126600000	usd
CY2022Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	134500000	usd
CY2021Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	107900000	usd
CY2023	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	171300000	usd
CY2022	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	155300000	usd
CY2022	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	150100000	usd
CY2023	us-gaap	Standard Product Warranty Accrual Additions From Business Acquisition StandardProductWarrantyAccrualAdditionsFromBusinessAcquisition	0	usd
CY2022	us-gaap	Standard Product Warranty Accrual Additions From Business Acquisition StandardProductWarrantyAccrualAdditionsFromBusinessAcquisition	0	usd
CY2023Q4	us-gaap	Accrual For Environmental Loss Contingencies Undiscounted Due After Fifth Year AccrualForEnvironmentalLossContingenciesUndiscountedDueAfterFifthYear	32600000	usd
CY2022	us-gaap	Standard Product Warranty Accrual Additions From Business Acquisition StandardProductWarrantyAccrualAdditionsFromBusinessAcquisition	33400000	usd
CY2023	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	161200000	usd
CY2022	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	163200000	usd
CY2022	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	156900000	usd
CY2023Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	136700000	usd
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	126600000	usd
CY2022Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	134500000	usd
CY2023	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	CONTINGENCIES<div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company is involved in various legal proceedings relating to environmental issues, employment, product liability, workers’ compensation claims and other matters. The Company periodically reviews the status of these proceedings with both inside and outside counsel, as well as an actuary for risk insurance. Management believes that the ultimate disposition of these matters will not have a material adverse effect on operations or financial condition taken as a whole.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Government Investigations </span></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">On January 19, 2024, the Company was notified by the Compliance and Field Operations Division (the “Division”) of the Consumer Product Safety Commission that the Division intends to recommend the imposition of a civil penalty of approximately $32 million for alleged untimely reporting in relation to certain utility bars and miter saws that were subject to voluntary recalls in September 2019 and March 2022, respectively. The Company is currently evaluating and believes there are defenses to the Division’s claims, and the Company is cooperating with the Division. However, given the early stage of this matter, at this time, the Company is not in a position to assess the likelihood of any potential loss or adverse effect on its financial condition or to estimate the amount of potential loss, if any, from this matter.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company previously disclosed that it had identified certain undisclosed perquisites in prior periods. The Company voluntarily disclosed this information to the U.S. Securities and Exchange Commission (the “SEC” or the “Commission”) and cooperated with the SEC’s investigation of this matter. On June 20, 2023, the SEC issued a Cease-and-Desist Order (the “Order”) that resolved this matter. The Order reflects that the Company neither admitted to nor denied the allegations contained in the Order, and that the SEC did not impose any monetary penalties on the Company. The Order credited the Company’s self-reporting, cooperation, and remediation efforts. In a parallel action, the SEC issued a Cease-and-Desist Order against a former executive of the Company (the “Parallel Resolution”). The SEC’s press release announcing both resolutions noted that, with respect to the Parallel Resolution, “[a]fter consideration of Stanley Black & Decker’s self-reporting, cooperation, and remediation, the SEC declined to bring charges against the company related to [the former executive’s] conduct.”</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Also, as previously disclosed, the Company has identified certain transactions relating to its international operations that may raise compliance questions under the U.S. Foreign Corrupt Practices Act (“FCPA”) and voluntarily disclosed this information to the U.S. Department of Justice (“DOJ”) and the SEC in January 2023. The Company is cooperating with both agencies in their investigations of these transactions (the “FCPA Matters”). Currently, the Company does not believe that the FCPA Matters will have a material impact on its financial condition or results of operations, although it is possible that a loss related to the FCPA Matters may be incurred.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Given the ongoing nature of the FCPA Matters, management cannot predict the duration, scope, or outcome of the DOJ’s or SEC’s investigations or estimate the potential magnitude of any such loss or range of loss, or the cost of the ongoing investigations. Any determination that certain transactions relating to the Company’s international operations were not in compliance with the FCPA could result in the imposition of fines, civil or criminal penalties, equitable remedies, including disgorgement, injunctive relief, or other sanctions against the Company. The Company also may become a party to litigation or other legal proceedings over the FCPA Matters described above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company is committed to upholding the highest standards of corporate governance and is continuously focused on ensuring the effectiveness of its policies, procedures, and controls. The Company is in the process, with the assistance of professional advisors, of reviewing and further enhancing relevant policies, procedures, and controls. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Class Action Litigation </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">As previously disclosed, on March 24, 2023, a putative class action lawsuit titled </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Naresh Vissa Rammohan v. Stanley Black & Decker, Inc., et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">., Case No. 3:23-cv-00369-KAD (the “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Rammohan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> Class Action”), was filed in the United States District Court for the District of Connecticut against the Company and certain of the Company’s current and former officers and directors. The complaint was filed on behalf of a purported class consisting of all purchasers of Stanley Black & Decker common stock between October 28, 2021 and July 28, 2022, inclusive. The complaint asserts violations of Sections 10(b) and 20(a) of the Exchange Act and Rule 10b-5 based on allegedly false and misleading statements related to consumer demand for the Company’s products amid changing COVID-19 trends and macroeconomic conditions. The complaint seeks unspecified damages and an award of costs and expenses. On October 13, 2023, Lead Plaintiff General Retirement System of the City of Detroit filed an Amended Complaint that asserts the same claims and seeks the same forms of relief as the original complaint. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company intends to vigorously defend this action in all respects and on December 14, 2023 filed a motion to dismiss the Amended Complaint in its entirety. Briefing on that motion is expected to conclude in April 2024. Given the early stage of this litigation, at this time, the Company is not in a position to assess the likelihood of any potential loss or adverse effect on its financial condition or to estimate the amount or range of potential losses, if any, from this action.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Derivative Actions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">As previously disclosed, on August 2, 2023 and September 20, 2023, derivative complaints were filed in the United States District Court for the District of Connecticut, titled </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Callahan v. Allan, et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">., Case No. 3:23-cv-01028-OAW (the “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Callahan </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Derivative Action”) and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Applebaum v. Allan, et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">., Case No. 3:23-cv-01234-OAW (the “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Applebaum</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> Derivative Action”), respectively, by putative stockholders against certain current and former directors and officers of the Company premised on the same allegations as the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Rammohan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> Class Action. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Callahan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Applebaum</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> Derivative Actions were consolidated by Court order on November 6, 2023 and defendants’ responses to both complaints have been stayed pending the disposition of any motions to dismiss in the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%"> Rammohan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> Class Action. The individual defendants intend to vigorously defend the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Callahan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Applebaum</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> Derivative Actions in all respects. However, given the early stage of this litigation, at this time, the Company is not in a position to assess the likelihood of any potential loss or adverse effect on its financial condition or to estimate the amount or range of potential losses, if any, from these actions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">On October 19, 2023, a derivative complaint was filed in Connecticut Superior Court, titled </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Vladimir Gusinsky Revocable Trust v. Allan, et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">., Docket Number HHBCV236082260S, by a putative stockholder against certain current and former directors and officers of the Company. Plaintiff seeks to recover for alleged breach of fiduciary duties and unjust enrichment under Connecticut state law premised on the same allegations as the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Rammohan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> Class Action. By Court order on November 11, 2023, the Connecticut Superior Court granted the parties’ motion to stay defendants’ response to the complaint pending the disposition of any motions to dismiss in the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%"> Rammohan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> Class Action. The individual defendants intend to vigorously defend this action in all respects. However, given the early stage of this litigation, at this time, the Company is not in a position to assess the likelihood of any potential loss or adverse effect on its financial condition or to estimate the amount or range of potential losses, if any, from this action.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Environmental</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company is a party to administrative proceedings and litigation, before federal and state regulatory agencies, relating to environmental remediation with respect to claims involving the discharge of hazardous substances into the environment, generally at current and former manufacturing facilities. In addition, some of these claims assert that the Company is responsible for damages and liability, for remedial investigation and clean-up costs, with respect to sites that have never been owned or operated by the Company, but the Company has been identified as a potentially responsible party ("PRP"). </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the 2010 merger with Black & Decker, the Company assumed certain commitments and contingent liabilities. Black & Decker is a party to litigation and administrative proceedings with respect to claims involving the discharge of hazardous substances into the environment at current and former manufacturing facilities and has also been named as a PRP in certain administrative proceedings.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company, along with many other companies, has been named as a PRP in numerous administrative proceedings for the remediation of various waste sites, including 23 active Superfund sites. Current laws potentially impose joint and several liabilities upon each PRP. In assessing its potential liability at these sites, the Company has considered the following: whether responsibility is being disputed, the terms of existing agreements, experience at similar sites, and the Company’s volumetric contribution at these sites.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s policy is to accrue environmental investigatory and remediation costs for identified sites when it is probable that a liability has been incurred and the amount of loss can be reasonably estimated. If no amount in the range of probable loss is considered most likely, the minimum loss in the range is accrued. The amount of liability recorded is based on an evaluation of currently available facts with respect to each individual site and includes such factors as existing technology, presently enacted laws and regulations, and prior experience in remediation of contaminated sites. The liabilities recorded do not take into account any claims for recoveries from insurance or third parties. As assessments and remediation progress at individual sites, the amounts recorded are reviewed periodically and adjusted to reflect additional technical and legal information that becomes available. As of December 30, 2023 and December 31, 2022, the Company had reserves of $124.5 million and $129.3 million, respectively, for remediation activities associated with Company-owned properties, as well as for Superfund sites, for losses that are probable and estimable. Of the December 30,</span><span style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023 amount, $46.0 million is classified as current and $78.5 million as long-term which is expected to be paid over the estimated remediation period. As of December 30, 2023, the range of environmental remediation costs that is reasonably possible is $79.9 million to $226.8 million which is subject to change in the near term. The Company may be liable for environmental remediation of sites it no longer owns. Liabilities have been recorded on those sites in accordance with the Company's policy.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 30, 2023, the Company has recorded $17.0 million in other assets related to funding received by the Environmental Protection Agency (“EPA”) and placed in a trust in accordance with the final settlement with the EPA, embodied in a Consent Decree approved by the United States District Court for the Central District of California on July 3, 2013. Per the Consent Decree, Emhart Industries, Inc. (a dissolved and liquidated former indirectly wholly-owned subsidiary of The Black & Decker Corporation) (“Emhart”) has agreed to be responsible for an interim remedy at a site located in Rialto, California and formerly operated by West Coast Loading Corporation (“WCLC”), a defunct company for which Emhart was alleged to be liable as a successor. The remedy will be funded by (i) the amounts received from the EPA as gathered from multiple parties, and, to the extent necessary, (ii) Emhart's affiliate. The interim remedy requires the construction of a water treatment facility and the filtering of ground water at or around the site for a period of approximately 30 years or more. As of December 30, 2023, the Company's net cash obligation associated with remediation activities, including WCLC assets, is $107.5 million. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The EPA also asserted claims in federal court in Rhode Island against Black & Decker and Emhart related to environmental contamination found at the Centredale Manor Restoration Project Superfund Site ("Centredale"), located in North Providence, Rhode Island. The EPA discovered a variety of contaminants at the site, including but not limited to, dioxins, polychlorinated biphenyls, and pesticides. The EPA alleged that Black & Decker and Emhart are liable for site clean-up costs under the Comprehensive Environmental Response, Compensation, and Liability Act ("CERCLA") as successors to the liability of Metro-Atlantic, Inc., a former operator at the site, and demanded reimbursement of the EPA’s costs related to this site. Black & Decker and Emhart then vigorously litigated the issue of their liability for environmental conditions at the Centredale site, including completing trial on Phase 1 of the proceedings in late July 2015 and completing trial on Phase 2 of the proceedings in April 2017. On July 9, 2018, a Consent Decree was lodged with the United States District Court documenting the terms of a settlement between the Company and the United States for reimbursement of EPA's past costs and remediation of environmental contamination found at the Centredale site. The terms of the Consent Decree were subject to public comment and Court approval. After a full hearing on March 19, 2019, the Court approved and entered the Consent Decree on April 8, 2019. The settlement resolves outstanding issues relating to Phase 1 and 2 of the litigation with the United States. The Company is complying with the terms of the settlement. The District Court's entry of the Consent Decree was appealed by several PRPs at the site to the United States Court of Appeals for the First Circuit. The District Court's actions were affirmed by the First Circuit on February 17, 2021. Phase 3 of the litigation, is addressing the potential allocation of liability to other PRPs who may have contributed to contamination of the Centredale site with dioxins, polychlorinated biphenyls and other contaminants of concern. As of December 30, 2023, the Company has a remaining reserve of $24.9 million for this site.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company and approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">47 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">other companies comprise the Lower Passaic Cooperating Parties Group (the “CPG”). The CPG members and other companies are parties to a May 2007 Administrative Settlement Agreement and Order on Consent (“AOC”) with the EPA to perform a remedial investigation/feasibility study (“RI/FS”) of the lower seventeen miles of the Lower Passaic River in New Jersey (the “River”). The Company’s potential liability stems from former operations in Newark, New Jersey. As an interim step related to the 2007 AOC, on June 18, 2012,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">the CPG members voluntarily entered into an AOC with the EPA for remediation actions focused solely at mile 10.9 of the River. The Company’s estimated costs related to the RI/FS and focused remediation action at mile 10.9, based on an interim allocation, are included in its environmental reserves. On April 11, 2014, the EPA issued a Focused Feasibility Study (“FFS”) and proposed plan which addressed various early action remediation alternatives for the lower 8.3 miles of the River. The EPA received public comment on the FFS and proposed plan (including comments from the CPG and other entities asserting that the FFS and proposed plan do not comply with CERCLA) which public comment period ended on August 20, 2014. The CPG submitted to the EPA a draft RI report in February 2015 and draft FS report in April 2015 for the entire lower seventeen miles of the River. On March 4, 2016, the EPA issued a Record of Decision ("ROD") selecting the remedy for the lower 8.3 miles of the River. The cleanup plan adopted by the EPA is now considered a final action for the lower 8.3 miles of the River and will include the removal of 3.5 million cubic yards of sediment, placement of a cap over the entire lower 8.3 miles of the River, and, according to the EPA, will cost approximately $1.4 billion and take 6 years to implement after the remedial design is completed. On September 30, 2016, Occidental Chemical Corporation ("OCC") entered into an agreement with the EPA to perform the remedial design for the cleanup plan for the lower 8.3 miles of the River. The remedial design is expected to be substantially completed in the first quarter of 2024. On June 30, 2018, OCC filed a complaint in the United States District Court for the District of New Jersey against over 100 companies, including the Company, seeking CERCLA cost recovery or contribution for past costs relating to various investigations and cleanups OCC has conducted or is conducting in connection with the River. According to the complaint, OCC has incurred or is incurring costs which include the estimated cost ($165 million) to complete the remedial design for the cleanup plan for the lower 8.3 miles of the River. OCC also seeks a declaratory judgment to hold the defendants liable for their proper shares of future response costs for OCC's ongoing activities in connection with the River. The Company and other defendants have answered the complaint and have been engaged in discovery with OCC. On February 24, 2021, the Company and other defendants filed a third party complaint against the Passaic Valley Sewerage Commissioners and forty-two municipalities to require those entities to pay their equitable share of response costs. On October 10, 2018, the EPA issued a letter directing the CPG to prepare a streamlined feasibility study for the upper 9 miles of the River based on an iterative approach using adaptive management strategies. The CPG submitted a revi</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">sed draft Interim </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Remedy Feasibility Study to the EPA on December 4, 2020, which identified various targeted dredge and cap alternatives with costs that range from $420 million to $468 million (net </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">present value). The EPA approved the Interim Remedy Feasibility Study on December 11, 2020. The EPA issued the Interim Remedy Proposed Plan on April 14, 2021 and the Interim Remedy ROD on September 28, 2021, selecting an alternative that the EPA estimates will cost $441 million (net present value). The CPG has substantially completed the RI/FS for the entire 17-mile River. The Company and 105 other parties received a letter dated March 31, 2016 from the EPA notifying such parties of potential liability for the costs of the cleanup of the lower 8.3 miles of the River and a letter dated March 30, 2017 stating that the EPA had offered 20 of the parties (not including the Company) an early cash out settlement. In a letter dated May 17, 2017, the EPA stated that these 20 parties did not discharge any of the eight hazardous substances identified as the contaminants of concern in the lower 8.3 mile ROD. In the March 30, 2017 letter, the EPA stated that other parties who did not discharge dioxins, furans or polychlorinated biphenyls (which are considered the contaminants of concern posing the greatest risk to human health or the environment) may also be eligible for cash out settlement, but expected those parties' allocation to be determined through a complex settlement analysis using a third-party allocator. The EPA subsequently clarified this statement to say that such parties would be eligible to be "funding parties" for the lower 8.3 mile remedial action with each party's share of the costs determined by the EPA based on the allocation process and the remaining parties would be "work parties" for the remedial action. The Company asserts that it did not discharge dioxins, furans or polychlorinated biphenyls and should be eligible to be a "funding party" for the lower 8.3 mile remedial action. The Company participated in the allocation process. The allocator selected by the EPA issued a confidential allocation report on December 28, 2020, which was reviewed by the EPA. As a result of the allocation process, on February 11, 2022, the EPA and certain parties (including the Company) reached an agreement in principle for a cash-out settlement for remediation of the entire 17-mile Lower Passaic River. On December 16, 2022, the United States lodged a Consent Decree with the United States District Court for the District of New Jersey in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">United States v. Alden Leeds, Inc. et al. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(No. 2:22-cv-07326) that addresses the liability of 85 parties (including the Company) for an aggregate amount of $150 million based on the EPA-sponsored allocation report that found OCC 99.4% responsible for the cleanup costs of the River. The Consent Decree was subject to a 90-day public comment period, which ended March 22, 2023. On November 21, 2023, the United States informed the Court that it concluded, based on the public comments, that a small number of parties (not including the Company) should be removed from the settlement, that a change should be made to the United States’ reservation of rights (which was agreed to by the remaining settling parties) and that it intends to file a Motion to Enter the modified Consent Decree (without soliciting additional public comments) no later than January 31, 2024. On December 12, 2023, the Court ordered the United States to file the proposed modified Consent Decree on or before January 17, 2024 and its Motion to Enter the modified Consent Decree no later than January 31, 2024 and established a schedule to complete briefing by July 2024. After the United States moves to enter the modified Consent Decree the Court will enter or disapprove. On December 20, 2022, various defendants (including the Company) in the OCC litigation filed an unopposed motion to stay the litigation for six months which was granted by the Court on March 1, 2023. On March 2, 2023, the EPA issued a Unilateral Administrative Order requiring OCC to design the interim remedy for the upper 9 miles of the River (the “2023 UAO”). Notwithstanding the stay of the litigation commenced in 2018 (and two days after the public comment period on the Consent Decree closed), OCC filed a complaint named </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Occidental Chem. Corp. v. Givaudan Fragrances Corp., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, No. 2:23‑cv-1699 at 2, 5 (D.N.J. Mar. 24, 2023) (the “2023 Litigation”) against forty parties (not including the Company) for recovery of past and future response costs it will incur in complying with the 2023 UAO. All of the defendants named in the 2023 Litigation are also defendants or third-party defendants in the litigation commenced in 2018. Pursuant to a settlement agreement by and among the Maxus Liquidating Trust, YPF and Repsol submitted to the bankruptcy court on April 7, 2023, YPF and Repsol will jointly pay a combined sum of $573 million to various creditors. Based on the waterfall payout of the bankruptcy plan, it is currently estimated that the CPG will receive approximately $9 million, which will be used either to offset future CPG costs, including EPA RI/FS oversight and legal and administrative costs, or to reimburse CPG members for a portion of their past contributions to the RI/FS costs</span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> At this time, the Company cannot reasonably estimate its liability related to the litigation and remediation efforts, excluding the RI/FS and remediation actions at mile 10.9, as the OCC litigation is pending and the EPA settlement process has not been completed and requires court approval.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Per the terms of a Final Order and Judgment approved by the United States District Court for the Middle District of Florida on January 22, 1991, Emhart is responsible for a percentage of remedial costs arising out of the Kerr McGee Chemical Corporation Superfund Site located in Jacksonville, Florida. On March 15, 2017, the Company received formal notification from the EPA that the EPA had issued a ROD selecting the preferred alternative identified in the Proposed Cleanup Plan. On or about November 2, 2023, the Multistate Trust managing the remediation revised the estimated remediation costs for work to be performed in 2024, and the Company adjusted the reserve for its percentage share of such costs accordingly. As of December 30, 2023, the Company has reserved $28.2 million for this site.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The environmental liability for certain sites that have cash payments beyond the current year that are fixed or reliably determinable have been discounted using a rate of 4.4% to 5.5%, depending on the expected timing of disbursements. The discounted and undiscounted amount of the liability relative to these sites is $34.3 million and $47.0 million, respectively. The payments relative to these sites are expected to be $3.2 million in 2024, $3.2 million in 2025, $3.2 million in 2026, $2.4 million in 2027, $2.4 million in 2028, and $32.6 million thereafter.</span></div><div style="margin-top:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount recorded for identified contingent liabilities is based on </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">estimates. Amounts recorded are reviewed periodically and adjusted to reflect additional technical and legal information that becomes available. Actual costs to be incurred in future periods may vary from the estimates, given the inherent uncertainties in evaluating certain exposures. Subject to the imprecision </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in estimating future contingent liability costs, the Company does not expect that any sum it may have to pay in connection with these environmental matters in excess of the amounts recorded will have a materially adverse effect on its financial position, results of operations or liquidity.</span></div>
CY2023Q4	swk	Superfund Sites SuperfundSites	23	site
CY2022	swk	Environmental Loss Contingency Statement Of Financial Position Extensible Enumeration Not Disclosed Flag EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag	reserves
CY2023	swk	Environmental Loss Contingency Statement Of Financial Position Extensible Enumeration Not Disclosed Flag EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag	reserves
CY2023	swk	Environmental Loss Contingency Noncurrent Statement Of Financial Position Extensible Enumeration Not Disclosed Flag EnvironmentalLossContingencyNoncurrentStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag	long-term
CY2023Q4	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	17000000	usd
CY2023	swk	Environmentalremediation.Periodconstructionoftreatmentfacilitytobemaintained Environmentalremediation.Periodconstructionoftreatmentfacilitytobemaintained	P30Y
CY2007Q2	swk	Environmental Remedial Investigation Feasibility Study Number Of Miles EnvironmentalRemedialInvestigationFeasibilityStudyNumberOfMiles	17	mi
CY2012Q2	swk	Environmental Remedial Investigation Feasibility Study Number Of Miles EnvironmentalRemedialInvestigationFeasibilityStudyNumberOfMiles	10.9	mi
CY2012Q2	swk	Environmental Remedial Investigation Feasibility Study Number Of Miles EnvironmentalRemedialInvestigationFeasibilityStudyNumberOfMiles	10.9	mi
CY2014Q2	swk	Environmental Remedial Investigation Feasibility Study Number Of Miles EnvironmentalRemedialInvestigationFeasibilityStudyNumberOfMiles	8.3	mi
CY2015Q2	swk	Environmental Remedial Investigation Feasibility Study Number Of Miles EnvironmentalRemedialInvestigationFeasibilityStudyNumberOfMiles	17	mi
CY2016Q1	swk	Environmental Remedial Investigation Feasibility Study Number Of Miles EnvironmentalRemedialInvestigationFeasibilityStudyNumberOfMiles	8.3	mi
CY2014Q2	swk	Environmental Remedial Investigation Feasibility Study Number Of Miles EnvironmentalRemedialInvestigationFeasibilityStudyNumberOfMiles	8.3	mi
CY2016Q1	swk	Environmental Remediation Cubic Yards Of Sediment EnvironmentalRemediationCubicYardsOfSediment	3500000	cubic_yard
CY2014Q2	swk	Environmental Remedial Investigation Feasibility Study Number Of Miles EnvironmentalRemedialInvestigationFeasibilityStudyNumberOfMiles	8.3	mi
CY2016Q1	us-gaap	Environmental Exit Costs Anticipated Cost EnvironmentalExitCostsAnticipatedCost	1400000000	usd
CY2016Q1	swk	Environmental Remediation Estimated Remedial Design Implementation Period EnvironmentalRemediationEstimatedRemedialDesignImplementationPeriod	P6Y
CY2016Q3	swk	Environmental Remedial Investigation Feasibility Study Number Of Miles EnvironmentalRemedialInvestigationFeasibilityStudyNumberOfMiles	8.3	mi
CY2018Q2	us-gaap	Loss Contingency Number Of Defendants LossContingencyNumberOfDefendants	100	company
CY2018Q2	swk	Environmental Remediation Estimated Remedial Design Cleanup Cost EnvironmentalRemediationEstimatedRemedialDesignCleanupCost	165000000	usd
CY2018Q2	swk	Environmental Remedial Investigation Feasibility Study Number Of Miles EnvironmentalRemedialInvestigationFeasibilityStudyNumberOfMiles	8.3	mi
CY2018Q2	swk	Environmental Remediation Number Of Municipalities Suit Filed EnvironmentalRemediationNumberOfMunicipalitiesSuitFiled	42	municipality
CY2018Q4	swk	Environmental Remedial Investigation Feasibility Study Number Of Miles EnvironmentalRemedialInvestigationFeasibilityStudyNumberOfMiles	9	mi
CY2021Q2	us-gaap	Environmental Exit Costs Anticipated Cost EnvironmentalExitCostsAnticipatedCost	441000000	usd
CY2021Q2	swk	Environmental Remedial Investigation Feasibility Study Number Of Miles EnvironmentalRemedialInvestigationFeasibilityStudyNumberOfMiles	17	mi
CY2016Q1	swk	Environmental Remediation Number Of Other Parties Notified EnvironmentalRemediationNumberOfOtherPartiesNotified	105	company
CY2016Q1	swk	Environmental Remedial Investigation Feasibility Study Number Of Miles EnvironmentalRemedialInvestigationFeasibilityStudyNumberOfMiles	8.3	mi
CY2017Q1	swk	Number Of Other Companies Offered Cash Out Settlements NumberOfOtherCompaniesOfferedCashOutSettlements	20	company
CY2017Q2	swk	Number Of Other Companies Offered Cash Out Settlements NumberOfOtherCompaniesOfferedCashOutSettlements	20	company
CY2017Q2	swk	Environmental Remediation Number Of Hazardous Substances EnvironmentalRemediationNumberOfHazardousSubstances	8	hazardoussubstance
CY2017Q2	swk	Environmental Remedial Investigation Feasibility Study Number Of Miles EnvironmentalRemedialInvestigationFeasibilityStudyNumberOfMiles	8.3	mi
CY2017Q1	swk	Environmental Remedial Investigation Feasibility Study Number Of Miles EnvironmentalRemedialInvestigationFeasibilityStudyNumberOfMiles	8.3	mi
CY2017Q1	swk	Environmental Remedial Investigation Feasibility Study Number Of Miles EnvironmentalRemedialInvestigationFeasibilityStudyNumberOfMiles	8.3	mi
CY2022Q1	swk	Environmental Remedial Investigation Feasibility Study Number Of Miles EnvironmentalRemedialInvestigationFeasibilityStudyNumberOfMiles	17	mi
CY2022Q4	swk	Environmental Remediation Number Of Parties EnvironmentalRemediationNumberOfParties	85	company
CY2022Q4	us-gaap	Environmental Exit Costs Anticipated Cost EnvironmentalExitCostsAnticipatedCost	150000000	usd
CY2022Q4	swk	Environmental Exit Costs Anticipated Cost Percentage EnvironmentalExitCostsAnticipatedCostPercentage	0.994
CY2023Q1	swk	Environmental Remedial Investigation Feasibility Study Number Of Miles EnvironmentalRemedialInvestigationFeasibilityStudyNumberOfMiles	9	mi
CY2023Q1	swk	Environmental Remediation Number Of Parties EnvironmentalRemediationNumberOfParties	40	company
CY2022Q4	swk	Environmental Remedial Investigation Feasibility Study Number Of Miles EnvironmentalRemedialInvestigationFeasibilityStudyNumberOfMiles	10.9	mi
CY2023	swk	Environmental Remediation Expense Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag EnvironmentalRemediationExpenseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag	estimated remediation costs
CY2023Q4	us-gaap	Accrual For Environmental Loss Contingencies Undiscounted Due Within One Year AccrualForEnvironmentalLossContingenciesUndiscountedDueWithinOneYear	3200000	usd
CY2023Q4	us-gaap	Accrual For Environmental Loss Contingencies Undiscounted Due In Second Year AccrualForEnvironmentalLossContingenciesUndiscountedDueInSecondYear	3200000	usd
CY2023Q4	us-gaap	Accrual For Environmental Loss Contingencies Undiscounted Due In Third Year AccrualForEnvironmentalLossContingenciesUndiscountedDueInThirdYear	3200000	usd
CY2023Q4	us-gaap	Accrual For Environmental Loss Contingencies Undiscounted Due In Fourth Year AccrualForEnvironmentalLossContingenciesUndiscountedDueInFourthYear	2400000	usd
CY2023Q4	us-gaap	Accrual For Environmental Loss Contingencies Undiscounted Due In Fifth Year AccrualForEnvironmentalLossContingenciesUndiscountedDueInFifthYear	2400000	usd

Files In Submission

Name	View Source	Status
0000093556-24-000032-index-headers.html	Edgar Link	pending
0000093556-24-000032-index.html	Edgar Link	pending
0000093556-24-000032.txt	Edgar Link	pending
0000093556-24-000032-xbrl.zip	Edgar Link	pending
a05ex4-descriptionofcompan.htm	Edgar Link	pending
ex-10kx311a10k2023.htm	Edgar Link	pending
ex-10kx311b10k2023.htm	Edgar Link	pending
ex-10kx32110k2023.htm	Edgar Link	pending
ex-10kx32210k2023.htm	Edgar Link	pending
ex21-subsidiariesofstanley.htm	Edgar Link	pending
ex23-consent10k2023.htm	Edgar Link	pending
ex24-powerofattorney10k2023.htm	Edgar Link	pending
exhibit1014i-rsuawardagree.htm	Edgar Link	pending
exhibit1014j1355_nqso2022o.htm	Edgar Link	pending
exhibit1014k1356_rsul3abov.htm	Edgar Link	pending
exhibit1014l1359_rsuretent.htm	Edgar Link	pending
exhibit1014m2024-micpgrant.htm	Edgar Link	pending
exhibit1014n-sbd2024ltipps.htm	Edgar Link	pending
exhibit1014o-sbd2024option.htm	Edgar Link	pending
exhibit1014p-sbd2024timeba.htm	Edgar Link	pending
exhibit1026-tamerofferlett.htm	Edgar Link	pending
exhibit97sbdclawbackpolicy.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image0a20.jpg	Edgar Link	pending
image0a201.jpg	Edgar Link	pending
image0a202.jpg	Edgar Link	pending
image0a203.jpg	Edgar Link	pending
image0a204.jpg	Edgar Link	pending
image0a205.jpg	Edgar Link	pending
image0a206.jpg	Edgar Link	pending
image_0.jpg	Edgar Link	pending
image_01.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R121.htm	Edgar Link	pending
R122.htm	Edgar Link	pending
R123.htm	Edgar Link	pending
R124.htm	Edgar Link	pending
R125.htm	Edgar Link	pending
R126.htm	Edgar Link	pending
R127.htm	Edgar Link	pending
R128.htm	Edgar Link	pending
R129.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R130.htm	Edgar Link	pending
R131.htm	Edgar Link	pending
R132.htm	Edgar Link	pending
R133.htm	Edgar Link	pending
R134.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
swk-20231230.htm	Edgar Link	pending
swk-20231230.xsd	Edgar Link	pending
swk-20231230_g1.jpg	Edgar Link	pending
swk-20231230_cal.xml	Edgar Link	unprocessable
swk-20231230_def.xml	Edgar Link	unprocessable
swk-20231230_lab.xml	Edgar Link	unprocessable
swk-20231230_pre.xml	Edgar Link	unprocessable
swk-20231230_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SWK
STANLEY BLACK & DECKER, INC. Stock $swk

2024 Q1 Form 10-K Financial Statement

#000009355624000032 Filed on February 27, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SWK STANLEY BLACK & DECKER, INC. Stock $swk

2024 Q1 Form 10-K Financial Statement

#000009355624000032 Filed on February 27, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SWK
STANLEY BLACK & DECKER, INC. Stock $swk